OR WAIT null SECS
March 01, 2022
AstraZeneca and Neuroimmune have closed an exclusive global collaboration and license agreement to develop and commercialize NI006.
BioMed X and Boehringer Ingelheim have announced the start of a new research project in brain sensor development.
UCB has announced that it is extending its tender offer to acquire Zogenix.
February 28, 2022
EMA has recommended granting a marketing authorization in the EU for Kimmtrak (tebentafusp), a new medicine for a rare type of eye cancer.
EMA has recommended approval of Spikevax for children aged 6 to 11.
Pfizer and BioNTech receive positive opinion for COVID-19 vaccine booster in adolescents 12 through 17 years of age in the EU.
February 24, 2022
Medicago and GSK have announced that Health Canada has approved COVIFENZ, an adjuvanted plant-based COVID-19 vaccine.
February 23, 2022
Sanofi and GSK announce they are seeking regulatory authorization for COVID-19 vaccine.
MHRA has opened a consultation on the proposed changes to clinical trial legislation in the UK.
Novavax announces the first doses of Nuvaxovid COVID-19 vaccine have begun shipping to European Union member states.